Highlights
NASDAQ: BGNE       Beigene Ltd Ads
Last Price Today's Change   Day's Range   Trading Volume
166.09   +0.75 (0.45%)  160.68 - 168.29  229,500

Overview

 
Avg Volume (4 weeks):290,578
4 Weeks Range:145.06 - 178.56
4 Weeks Price Volatility (%):
62.78%
52 Weeks Range:65.58 - 220.10
52 Weeks Price Volatility (%):
65.05%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

BeiGene Ltd is a United States based clinical-stage biopharmaceutical company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1.

  Be the first to like this.
 


 

3737  3791  858  211 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 HMNY 0.15-0.033 
 BAC 28.55-0.22 
 XLF 26.98-0.12 
 T 31.67-0.56 
 CSCO 41.78-1.80 
 GE 13.89-0.10 
 SPY 279.59+0.22 
 AMD 16.27-0.29 
 EEM 43.85+0.03 
 CEI 0.58+0.205 
Partners & Brokers